XP (NASDAQ:XP) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

XP logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • XP reported quarterly EPS of $0.52, missing analysts’ $0.54 consensus estimate by $0.02; return on equity was 22.19% and net margin was 27.20%.
  • Shares fell 4.3% to $14.83 on Monday, with trading volume above the stock’s average.
  • Analyst views were mixed, with five Buy and five Hold ratings; the average price target was $24.86, though some firms recently cut targets or downgraded the stock.
  • MarketBeat previews top five stocks to own in December.

XP (NASDAQ:XP - Get Free Report) announced its earnings results on Monday. The company reported $0.52 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by ($0.02), Zacks reports. XP had a return on equity of 22.19% and a net margin of 27.20%.

XP Trading Down 4.3%

Shares of XP traded down $0.66 during trading hours on Monday, reaching $14.83. The stock had a trading volume of 8,363,616 shares, compared to its average volume of 7,904,622. XP has a 52 week low of $13.78 and a 52 week high of $32.73. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.07. The company has a market cap of $7.97 billion, a P/E ratio of 7.76, a P/E/G ratio of 0.36 and a beta of 1.18. The firm has a 50-day moving average of $21.76 and a 200 day moving average of $19.02.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on XP shares. JPMorgan Chase & Co. lifted their price target on XP from $26.00 to $38.00 and gave the company an "overweight" rating in a report on Tuesday, October 6th. The Goldman Sachs Group lowered their price target on XP from $36.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday. Citigroup cut shares of XP from a "buy" rating to a "neutral" rating and cut their target price for the company from $25.00 to $15.00 in a research note on Tuesday, October 27th. Morgan Stanley set a $23.00 price objective on XP in a report on Thursday, October 29th. Finally, Santander lowered shares of XP to a "neutral" rating in a research report on Thursday, October 29th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $24.86.

Get Our Latest Research Report on XP

Insider Activity

In related news, Director Bruno Constantino Alexandre dos Santos sold 123,257 shares of the firm's stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $19.58, for a total transaction of $2,413,372.06. Following the sale, the director directly owned 1,500,000 shares in the company, valued at $29,370,000. This trade represents a 7.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

About XP

(Get Free Report)

XP Inc. is a Brazil-based financial services company that operates a digital investment platform. It offers individuals and businesses access to investment products and services, including brokerage, investment advice and wealth management. The company has expanded beyond investing into banking, credit, insurance and asset management. Its businesses include the XP, Rico and Clear platforms, which serve customers with different investment needs and preferences. Founded in 2001 as an investment advisory business, XP has grown into a broad financial services provider focused primarily on the Brazilian market.

Featured Stories

Earnings History for XP (NASDAQ:XP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in XP Right Now?

Before you consider XP, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and XP wasn't on the list.

While XP currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines